May 31, 2019 Preference for digital channels has risen steadily since 2015, while the appeal of Sales Representatives has plateaued, Gaurav Kapoor, Indegene Co-Founder and Executive Vice President, said. One reason doctors want more digital contact? More administrative work leaves less time to see Sales Reps even as complex drugs require more education. That could … Read more
May 28, 2019 One question remains constant: How can we effectively treat pain, while reducing the ever-increasing numbers of opioid prescriptions flowing into U.S. homes? The answer is to eliminate or significantly reduce the need for opioids from the time that the pain occurs and when the first prescription is written. In a March 2017 … Read more
May 23, 2019 This idea had been in the back of Fenner’s mind for a while. Her son was diagnosed with Type 1 diabetes nine (9) years ago, meaning he needs daily injections of insulin to live. The list price of the modern generation of insulin has skyrocketed since his diagnosis. On one trip to … Read more
May 21, 2019 The cases are related to breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a type of non-Hodgkin’s lymphoma that can develop in the scar tissue surrounding an implant. The Agency first alerted the public to the risks of the disease in 2011, and has been tracking known cases of BIA-ALCL, deaths and risk … Read more
May 17, 2019 A study published in January 2019 in the Journal of the American Medical Association (AMA) adds to a growing body of evidence suggesting that human-derived formulations of insulin are as clinically effective at treating Type 2 diabetes as pricier “designer” analogues that get used more commonly. That could offer patients relief from … Read more
May 09, 2019 The mutation, which occurs in a gene regulator called TERT and is the most common mutation in glioblastoma, gives cancer cells “immortality,” or the ability to divide and spread indefinitely. By studying cells from glioblastoma patients, the UCSF researchers discovered that a particular form of a protein called GABP drives TERT promoter … Read more
May 07, 2019 In August 2019, the Senate voted to include legislation from Sen. Chuck Grassley, R-Iowa, and Sen. Dick Durbin, D-Ill., that directs the HHS to form rules about requiring pharmaceutical pricing in DTC advertising. The legislation came in the form of an amendment to a healthcare spending bill; the House of Representatives still … Read more
April 30, 2019 During his visit to the World Economic Forum in Davos, Switzerland, the head of Her Majesty’s Treasury, Chancellor of the Exchequer Philip Hammond, described the move as a way to help future-proof the U.K. economy going forward. The money is part of the country’s Industrial Strategy and will fund research into technology for … Read more
April 25, 2019 Looking at health insurance claims from 13,800 to 16,200 people with Type 1 diabetes who use employer-sponsored health insurance, researchers found insulin spending per person in the U.S. was $5,700 in 2016, a 97% increase from $2,900 in 2012. The average annual cost for individuals to manage their diabetes reached $18,500 in 2016, … Read more
April 23, 2019 In a 355-page lawsuit, UnitedHealthcare sued the companies for collusion, naming a group of “core conspirators” that includes Teva and Mylan, as well as dozens of other drugmakers. UnitedHealthcare, the largest insurer in the U.S., aims to claw back financial losses it says it suffered because of the inflated prices. Filed in Minnesota … Read more